Titan Biotech Ltd Financials

Titan Biotech Ltd Financial Statement

Titan Biotech Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	40.21	43.74	40.40
Operating Expense	32.13	34.87	32.84
Net Profit	5	5.70	4.84
Net Profit Margin	12.43	13.03	11.98
Earning Per Share	6.05	6.90	5.86
EBIDTA	8	8.88	7.49
Effective Tax Rate	20.17	20.52	19.44

Particulars	Sep 2024
Revenue	40.21
Operating Expense	32.13
Net Profit	5.00
Net Profit Margin	12.43
Earning Per Share	6.05
EBIDTA	8.00
Effective Tax Rate	20.17

Titan Biotech Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	164.07	144.00	123.55
Operating Expenses Annual	129.79	114.48	92.28
Operating Profit Annual	36.03	31.46	32.21
Interest Annual	1.17	0.75	0.87
Depreciation	2.84	2.12	2.35
Net Profit Annual	23.66	21.02	21.68
Tax Annual	7.87	7.09	7.28

Particulars	Mar 2024
Total Revenue Annual	164.07
Operating Expenses Annual	129.79
Operating Profit Annual	36.03
Interest Annual	1.17
Depreciation	2.84
Net Profit Annual	23.66
Tax Annual	7.87

Titan Biotech Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	4.86	6.81	5.31
Cash Flow from Operations	21.15	21.18	22.04
Cash Flow from Investing	-20.30	-20.73	-16.44
Cash Flow from Financing	-2.87	-2.40	-4.10
Cash Flow at the End	2.84	4.86	6.81

Particulars	Mar 2024
Cash Flow at the Beginning	4.86
Cash Flow from Operations	21.15
Cash Flow from Investing	-20.30
Cash Flow from Financing	-2.87
Cash Flow at the End	2.84

Titan Biotech Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	21.96	21.85	26.07
PBIT Margin (%)	19.93	20.05	24.15
PBT Margin (%)	2.89	-6.67	-3.60
Net PROFIT Margin (%)	14.42	14.60	17.55
Return On Networth / Equity (%)	20.18	21.86	28.52
Return On Networth /Employed (%)	25.70	27.12	34.30
Return On Assets (%)	18.60	19.71	24.92
Total Debt / Equity (X)	0.07	0.09	0.13
Asset Turnover Ratio (%)	1.29	1.35	1.42

Particulars	Mar 2024
PBDIT Margin (%)	21.96
PBIT Margin (%)	19.93
PBT Margin (%)	2.89
Net PROFIT Margin (%)	14.42
Return On Networth / Equity (%)	20.18
Return On Networth /Employed (%)	25.70
Return On Assets (%)	18.60
Total Debt / Equity (X)	0.07
Asset Turnover Ratio (%)	1.29

Titan Biotech Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	52.03	35.89	34.99
Total Current Assets Annual	72.17	68.31	63.76
Non Current Assets Annual	79.40	62.39	44.34
Total Shareholders Funds Annual	128.44	106.09	86.24
Total Assets Annual	151.57	130.70	108.09

Particulars	Mar 2024
Fixed Assets Annual	52.03
Total Current Assets Annual	72.17
Non Current Assets Annual	79.40
Total Shareholders Funds Annual	128.44
Total Assets Annual	151.57

Titan Biotech Ltd Earning Calls

EPS (INR)

Expected

8.11

Reported

8.10

Surprise

-0.12%

Jun 2024

EPS beaten by -0.12%

Mar 2024

EPS beaten by -0.13%

Dec 2023

EPS beaten by 0.00%

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, Titan Biotech Ltd has a market capitalization of 436.49 Cr. Value Research classifies it as a Small-Cap company.

Yes, Titan Biotech Ltd is debt-free with a debt-to-equity ratio of 0.06.

In FY 2023 , Titan Biotech Ltd recorded a total revenue of approximately 164.07 Cr marking a significant milestone in the company's financial performance.

Titan Biotech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.1% annually, respectively..

Titan Biotech Ltd's current PE ratio is 18.45.

Titan Biotech Ltd's ROCE averaged 26.8% from the FY ending March 2022 to 2024, with a median of 25.2%. It peaked at 31.4% in March 2022, reflecting strong capital efficiency over the period..

Titan Biotech Ltd's latest EBIT is Rs. 32.70 Cr, surpassing the average EBIT of Rs. 30.47 Cr over the 5 years..